The bill amends Section 3 of Act No. 324 from the 2023 Regular Session of the Louisiana Legislature, specifically regarding the implementation of biomarker testing provisions. It removes the previous requirement that the act would only become effective upon a specific appropriation of funds by the legislature. Instead, the new language states that the act will take effect upon the governor's signature or, if not signed, after the designated time for bills to become law without a signature. If the governor vetoes the bill and it is later approved by the legislature, the act will become effective the day after that approval.

Additionally, the bill clarifies that its provisions will apply to any new policy, contract, program, or health coverage plan issued on or after January 1, 2025. This change aims to streamline the implementation process for biomarker testing and ensure that the provisions are applicable to future health coverage plans.